Publicacións en colaboración con investigadores/as de Universidade de Santiago de Compostela (107)

2024

  1. Cough severity visual analog scale scores and quality of life in patients with refractory or unexplained chronic cough

    Respiratory Investigation, Vol. 62, Núm. 6, pp. 987-994

  2. Exploring CD26−/lo subpopulations of lymphocytes in asthma phenotype and severity: A novel CD4+ T cell subset expressing archetypical granulocyte proteins

    Allergy: European Journal of Allergy and Clinical Immunology

  3. New Vaccines for Chronic Respiratory Patients

    Archivos de Bronconeumologia, Vol. 60, Núm. 9, pp. 565-575

  4. Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study

    Inflammopharmacology, Vol. 32, Núm. 4, pp. 2305-2315

  5. Signature Proteins in Small Extracellular Vesicles of Granulocytes and CD4+ T-Cell Subpopulations Identified by Comparative Proteomic Analysis

    International Journal of Molecular Sciences, Vol. 25, Núm. 19

  6. The role of traditional NSAIDs and selective COX-2 inhibitors on COVID-19 outcomes: a real-world data study

    Inflammopharmacology

2023

  1. A Study of the Prevalence of Asthma in the General Population in Spain

    Open Respiratory Archives, Vol. 5, Núm. 2

  2. Burden of refractory and unexplained chronic cough on patients’ lives: a cohort study

    ERJ Open Research, Vol. 9, Núm. 5

  3. Exacerbations Among Patients With Asthma Are Largely Dependent on the Presence of Multimorbidity

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 4, pp. 281-288

  4. Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 223-231

  5. Impact of Air Pollution on Asthma: A Scoping Review

    Open Respiratory Archives, Vol. 5, Núm. 2

  6. Omalizumab in Severe Asthma: Effect on Oral Corticosteroid Exposure and Remodeling. A Randomized Open-Label Parallel Study

    Drugs, Vol. 83, Núm. 12, pp. 1111-1123

  7. Outpatient atorvastatin use and severe COVID-19 outcomes: A population-based study

    Journal of Medical Virology, Vol. 95, Núm. 7

  8. Prognostic Usefulness of Basic Analytical Data in Chronic Obstructive Pulmonary Disease Exacerbation

    Open Respiratory Archives, Vol. 5, Núm. 4

  9. Serum exosome inflamma-miRs are surrogate biomarkers for asthma phenotype and severity

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 1, pp. 141-155

  10. Severe asthma patients’ and physicians’ perspectives of disease burden: do they match?

    ERJ Open Research

  11. Treatment Patterns of Monoclonal Antibodies in Patients With Severe Uncontrolled Asthma Treated by Pulmonologists in Spain

    Open Respiratory Archives, Vol. 5, Núm. 3

2022

  1. Association of rhinitis with asthma prevalence and severity

    Scientific Reports, Vol. 12, Núm. 1

  2. Correction to: Impact of anxiety and depression on the prognosis of copd exacerbations (BMC Pulmonary Medicine, (2022), 22, 1, (169), 10.1186/s12890-022-01934-y)

    BMC Pulmonary Medicine

  3. Development and Validation of a Knowledge, Attitude and Practice Questionnaire on Antibiotic Use in Arabic and French Languages in Lebanon

    International Journal of Environmental Research and Public Health, Vol. 19, Núm. 2